CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

Journal of Neuroimmunology

Volumn 211, Issue 1-2, 2009, Pages 101-104

  Villar, Luisa M ^a   Masterman, Thomas ^b   Casanova, Bonaventura ^c   Gómez Rial, José ^a   Espiño, Mercedes ^a   Sádaba, María C ^a   González Porqué, Pedro ^a   Coret, Francisco ^c   Álvarez Cermeño, José C ^a,d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Departments of Neurology   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Multiple sclerosis; Oligoclonal IgG bands; Oligoclonal IgM bands

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS;

EID: 67349197281     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.03.003     Document Type: Article

References (27)

1. Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L.M., Grønning M., Keir G., Lamers K., Link H., Magalhães A., Massaro A.R., Öhman S., Reiber H., Rönnbäck L., Schuep M., Schuller E., Sindic C.J.M., Thompson E.J., Trojano M., and Wurster U. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 57 (1994) 897-902
2. Bielekova B., Kadom N., Fisher E., Jeffries N., Ohayon J., Richert N., Howard T., Bash C.N., Frank J.A., Stone L., Martin R., Cutter G., and McFarland H.F. MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology 65 (2005) 1071-1076
3. Breij E.C.W., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., and Bö L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 63 (2008) 16-25
4. Confavreux C., Vukusic S., Moreau T., and Adeleine P. Relapses and progression of disability in multiple sclerosis. N. Engl. J. Med. 343 (2000) 1430-1438
5. Confavreux C., Vukusic S., and Adeleine P. Early clinical predictors and progression of irreversible disability in MS: an amnesic process. Brain 126 (2003) 770-782
6. Gay F.W., Drye T.J., Dick G.W., and Esiri M.M. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Brain 120 (1997) 1461-1483
7. Greer J.M., Csurhes P.A., Muller D.M., and Pender M.P. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. J. Immunol. 180 (2008) 6402-6410
8. Imrrell K., Landtblom A.M., Hillert J., and Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67 (2006) 1062-1064
9. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
10. Link H., and Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 37 (1977) 397-401
11. Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
12. Masjuan J., Álvarez-Cermeño J.C., García -Barragán N., Díaz-Sánchez M., Espiño M., Sádaba M.C., González-Porqué P., Martínez San Millán J., and Villar L.M. Clinically isolated syndromes. A new oligoclonal band test accurately predicts conversion to MS. Neurology 66 (2006) 576-578
13. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
14. McLean B.N., Luxton R.W., and Thompson E.J. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 113 (1990) 1269-1289
15. McLean B.N., Zeman A.Z., Barnes D., and Thompson E.J. Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 56 (1993) 356-360
16. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
17. Obermeier B., Mentele R., Malotka J., Kellermann J., Kümpfel T., Wekerle H., Lottspeich F., Hohlfeld R., and Dornmair K. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat. Med. 14 (2008) 688-693
18. Sádaba M.C., Gonzalez-Porqué P., Masjuan J., Álvarez-Cermeño J.C., Bootello A., and Villar L.M. An ultrasensitive method for the detection of oligoclonal IgG bands. J. Immunol. Methods 284 (2004) 141-145
19. Söderström M., Ya-Ping J., Hillert J., and Link H. Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50 (1998) 708-714
20. Thangarajh M., Gomez-Rial J., Hedström A.K., Hillert J., Alvarez-Cermeño J.C., Masterman T., and Villar L.M. Lipid-specific immunoglobulin M in CSF predicts adverse. Mult. Scler. 14 (2008) 1208-1213
21. Villar L.M., González-Porqué P., Masjuan J., Alvarez-Cermeño J.C., Bootello A., and Keir G. Sensitive and reproducible method for the detection of oligoclonal IgM bands. J. Immunol. Methods 258 (2001) 151-155
22. Villar L.M., Masjuan J., González-Porqué P., Plaza J., Sádaba M.C., Roldán E., Bootello A., and Álvarez-Cermeño J.C. Intrathecal IgM synthesis in neurological diseases. Relationship with disability in MS. Neurology 58 (2002) 824-826
23. Villar L.M., Masjuan J., Sádaba M.C., González-Porqué P., Plaza J., Bootello A., and Álvarez-Cermeño J.C. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test. Arch. Neurol. 62 (2005) 574-577
24. Villar L.M., Sádaba M.C., Roldán E., González-Porqué P., Plaza J., Bootello A., and Álvarez-Cermeño J.C. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J. Clin. Invest. 115 (2005) 187-194
25. Villar L.M., García-Barragán N., Espiño M., Roldán E., Sádaba M.C., Gómez-Rial J., González-Porqué P., and Álvarez-Cermeño J.C. Influence of oligoclonal IgM specificity in multiple sclerosis disease course. Mult. Scler. 14 (2008) 183-187
26. Zeman A.Z., Keir G., Luxton R., and Thompson E.J. Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source. QJM 89 (1996) 187-193
27. Zwemmer J.N.P., Berkhof J., Castelijns J.A., Barkhof F., Polman C.H., and Uitdehaag B.M. Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics. Mult. Scler. 12 (2006) 565-572